Financial Results For The Half Year Ended September 30, 2025
Filed with BSE · · 9 pages · English
November 14, 2025 Secunderabad 1. The Unaudited Standalone and Consolidated Financial Results of the Company for the half year ended September 30, 2025, along with Limited Review Report thereon. A copy of the said Results along with the Limited Review Report are enclosed herewith. The meeting commenced at 06.00 PM and concluded at 7:00 PM. This for your information and dissemination to the public.
Earlier from Vanta Bioscience
- Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2025
- Vanta Bioscience Ltd. Press Release Nov 01 2025
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Reg. 34 (1) Annual Report.
- Vanta Bioscience Ltd. Press Release Oct 03 2025
Later from Vanta Bioscience
- Clarification On Movement In Price
- Vanta Bioscience Ltd. Press Release Mar 11 2026
- Closure of Trading Window
- Vanta Bioscience Ltd. Press Release Mar 24 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Vanta Bioscience into a list and get an email when it puts out news.
Follow Vanta Bioscience